Cargando…
Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer
BACKGROUND: Immune‐related adverse events (irAEs) should be anticipated with treatment by immune checkpoint inhibitors (ICIs). Although the relationship between irAEs and efficacy of ICI has been reported, it has not yet been clarified whether the benefit from ICI outweighs the low frequency of proc...
Autores principales: | Komiya, Kazutoshi, Nakamura, Tomomi, Abe, Tomonori, Ogusu, Shinsuke, Nakashima, Chiho, Takahashi, Koichiro, Kimura, Shinya, Sueoka‐Aragane, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718019/ https://www.ncbi.nlm.nih.gov/pubmed/31328416 http://dx.doi.org/10.1111/1759-7714.13149 |
Ejemplares similares
-
Sjögren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis
por: Takahashi, Koichiro, et al.
Publicado: (2018) -
Paraneoplastic Limbic Encephalitis Complicated with Small Cell Lung Cancer at the Time of Recurrence
por: Sadamatsu, Hironori, et al.
Publicado: (2019) -
Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
por: Sato, Akemi, et al.
Publicado: (2018) -
Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments
por: Nakashima, Chiho, et al.
Publicado: (2018) -
SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
por: Komiya, Kazutoshi, et al.
Publicado: (2016)